Shares of Syncona (LON:SYNC – Get Free Report) hit a new 52-week high on Tuesday. The company traded as high as GBX 124 and last traded at GBX 124, with a volume of 284641 shares. The stock had previously closed at GBX 122.20.
Wall Street Analysts Forecast Growth
Separately, Peel Hunt reaffirmed a “buy” rating and issued a GBX 189 price objective on shares of Syncona in a research report on Tuesday, August 4th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, Syncona has an average rating of “Buy” and a consensus price target of GBX 189.
Check Out Our Latest Stock Analysis on SYNC
Syncona Trading Up 0.9%
Syncona Company Profile
Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.
See Also
- Five stocks we like better than Syncona
- Bernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
Receive News & Ratings for Syncona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syncona and related companies with MarketBeat.com's FREE daily email newsletter.
